Fig. 3: Recurrent gene-level mutations and copy number alterations across Ewing sarcoma cases with (including Tier 1 and Tier 2) and without germline pathogenic/likely pathogenic (P/LP) variants.
Oncoplot showing recurrent mutations and copy number alterations in Ewing sarcoma with and without germline P/LP variants.
